Alabama MRI facility promises patients a ‘spa-like’ atmosphere

Michael Walter | | Health Exec | Precision Medicine

Can’t stand crowded waiting rooms? A new imaging center in Prattville, Ala., might be exactly what you’ve been waiting for all this time.

Sonos Imaging, a new MRI facility that held its grand opening this week, promises patients a “luxury” and “spa-like” experience. Waiting rooms have been replaced with “individual lounges,” which include internet access, a television and private changing rooms.

According to a Montgomery Advertiser report, the company is planning more locations throughout Alabama, including one in Birmingham within the next year.

As the healthcare industry continues to shift from quantity to quality, could more luxurious facilities be in the future?

Click below to read the full story:

'Spa-like' imaging center opens Tuesday in Prattville

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.